| |
T2DM
|
Non-DM Controls
|
|---|
|
Number
|
41
|
40
|
|
Age (years)
|
45 (41–49)
|
39 (37–45)
|
|
Duration of DM (years)
|
9 (5–12)
|
NA
|
|
BMI (kg/m2)
|
26 (23–31)
|
25 (23–29)
|
|
HbA1C (%)
|
10 (7.7–11.6)
|
5.5 (5.2–5.8)
|
|
Creatinine (mg/dl)
|
0.6 (0.5–0.8)
|
0.7 (0.6–0.7)
|
|
eGFR (mL/min/1,73 m2)
|
106 (87–115)
|
110 (106–116)
|
|
SGPT (U/l)
|
19 (11–25)
|
16 (11–21)
|
|
Triglycerides (mg/dl)
|
158 (96–198)
|
ND
|
|
LDL (mg/dl)
|
141 (117–163)
|
ND
|
|
HDL (mg/dl)
|
49 (38–54)
|
ND
|
|
Total cholesterol (mg/dl)
|
197 (179–230)
|
ND
|
|
Antidiabetics
|
|
- Metformin (%)
|
7 (17)
|
NA
|
|
- Metformin + Sulfonylurea (%)
|
11 (27)
|
NA
|
|
- Insulin (%)
|
14 (34)
|
NA
|
|
- Combined therapy (%)
|
8 (20)
|
NA
|
|
- No treatment (%)
|
1 (2)
|
NA
|
- Data depicted are median with interquartile range (IQR) unless otherwise indicated. Statistical differences are analyzed by using T-test or Mann-Whitney U test. NA, not applicable; ND, not determined
